Market access strategies
Strategic insights and research
Value demonstration
Value communication
Commercialization support and vendor management
Case studies
Thought leadership


In today’s global marketplace, payers are demanding that the value of a product extend beyond clinical efficacy and utility as demonstrated in randomized clinical trials. Further evidence of effectiveness and comparative effectiveness in real-world populations, in addition to cost-effectiveness, are being increasingly encouraged and required for coverage and pricing decisions within health technology assessments (HTAs). Our health economics and outcomes research experts can assist in providing recommendations and strategies for the development of such evidence as well as successfully conduct these analyses in a timely and efficient manner, utilizing all of the most current modeling and statistical methods as well as adhering to best practices for conducting the evaluation and reporting the results.